THE EXTRACELLULAR MATRIX (ECM) plays a critical role in highly specialized cellular functions, including differentiation, migration, and proliferation (5, 21, 45, 46) . The composition and structure of the ECM differs from tissue to tissue and can undergo continuous changes within the same tissue, thereby having both temporal and spatial effects on cells that come into contact with it. These changes result in part from the regulation of the synthesis and secretion of the glycoproteins that are incorporated into the ECM.
Unlike terminally differentiated myocytes, mature smooth muscle cells can reenter the cell cycle in response to physiopathological stimuli (35) . Dedifferentiation and proliferation of vascular smooth muscle cells (VSMCs) contribute to the pathogenesis of vascular occlusive disease, including atherosclerosis, restenosis after angioplasty, and bypass graft occlusion. Inhibition of VSMC proliferation has been shown to attenuate restenosis after balloon angioplasty in several animal models (12, 50) . VSMC proliferation induced by growth factors in vitro and balloon injury in vivo is associated with changes in the expression of ECM proteins and their corresponding cellular receptors, which may play an important role as physiological regulators of cell cycle progression during atherosclerosis and restenosis (2) . One of the ECM components for which dramatic regulatory changes have been observed is thrombospondin-1 (TSP1), a member of a family of related glycoproteins (TSP1 through TSP5) (3, 4, 10, 24, 25, 34, 41) . TSP1 is secreted by numerous cell types, including platelets, endothelial cells, macrophages, fibroblasts, and VSMCs (19, 20, 25, 31, 33, 43) . TSP1 expression is rapidly upregulated on serum or growth factor stimulation of cultured VSMCs (11, 28, 30) , and TSP1 protein and mRNA are elevated with both intimal hyperplasia and hypercholesterolemia in vivo (26, (42) (43) (44) 56) . Although TSP1 appears to be important for the proliferation of VSMCs (27, 29) and fibroblasts (38) it inhibits endothelial cell growth in vitro (54) and angiogenesis in vivo (13, 18) . However, the molecular mechanisms by which TSP1 exerts these cell type-specific functions are not well understood.
Cell cycle progression is facilitated by the sequential activation of a family of cyclin-dependent kinases (cdks), which requires their association with specific subunits called cyclins (15, 32, 49) . cdk2 activity is negatively regulated by members of the growth suppressor family of cdk inhibitors (CKIs), including p21 Cip1/WAF1 (p21) and p27 Kip1 (p27) (14, 16, 37) . In the present study we investigated the molecular pathways through which TSP1 regulates VSMC proliferation in vitro by using neutralizing anti-TSP1 monoclonal antibody A4.1. Our results demonstrate that A4.1-mediated growth arrest in serum-stimulated VSMCs is associated with the inhibition of cdk2-dependent kinase activity. Expression of p21 and its association with cdk2 complexes were induced on addition of A4.1 antibody to serumstimulated VSMCs. Moreover, A4.1 antibody blocked DNA synthesis in wild-type mouse embryonic fibroblasts (MEFs) but not in cells derived from p21-deficient mice. Together, these data demonstrate that antibody blockade of TSP1 inhibits cell cycle progression in a p21-dependent manner, and suggest the involvement of p21 in TSP1-mediated regulation of cellular proliferation.
METHODS
Cell culture. Cells were incubated at 37°C in a humidified 5% CO 2 -95% O 2 atmosphere in medium supplemented with 2 mM L-glutamine, 200 U/ml penicillin, 0.25 mg/ml streptomycin, and serum as indicated. Primary rat aortic VSMCs were isolated essentially as described (39) and maintained in DMEM supplemented with 10% fetal bovine serum (FBS, growth medium). MEFs derived from wild-type and p21-deficient mice (8) were maintained in DMEM containing 10% FBS. To enrich the population of cells in G 0 /G 1 , cultures were serum-starved for 3 days in DMEM supplemented with 0.2% FBS. The C2C12 murine skeletal myoblast cell line was obtained from American Type Culture Collection. Terminal differentiation of C2C12 myoblasts maintained in 20% FBS-DMEM was induced by switching cultures to 2% heatinactivated horse serum-DMEM (differentiation medium). Under these conditions, C2C12 cells permanently exit the cell cycle and then express differentiation markers (1) .
Anti-TSP1 antibody. The mouse monoclonal anti-TSP1 antibody A4.1, which recognizes the trypsin-resistant 70-kDa core of TSP1 (40) , was used in this study. Specificity of this antibody has been previously established by Western blotting against samples of whole platelets, serum, and purified proteins (40) . Mouse nonspecific IgM antibody MOPC-104E (M2521) was used as a control (Sigma Chemical).
[ 3 H]thymidine uptake analysis. Rat VSMCs and MEFs were plated in 24-well tissue culture plates in DMEM supplemented with 10% FBS. Cells were rendered quiescent by incubation for 3 days in DMEM containing 0.2% FBS and then cultures were restimulated with growth medium for 16-24 h. When indicated, cells were treated with different concentrations of anti-TSP1 antibody A4.1 (25-100 µg IgM/ml of medium). Cells were incubated in growth medium containing 3 µCi/ml of [ 3 H]thymidine (6.7 Ci/mmol, Dupont NEN) for the last 4-6 h. Cells were washed three times with PBS and incubated with cold 10% TCA for 1 h. After we removed the TCA solution, we rinsed the cells three times with water and the precipitated material was solubilized with 0.25 N NaOH. Tritium content in the sodium hydroxide solution was determined by adding Scintiverse II (Fisher Scientific) and measured using a Beckman LS 5000TD scintillation counter. The experiments were performed in triplicate wells. Parallel cultures of VSMCs and MEFs in 24-well plates were collected by trypsinization, and the cell numbers were determined under microscopy with a hemocytometer.
FACS analysis. Rat VSMCs were plated in 100-mm petri dishes in growth medium and allowed to attach before being transferred to DMEM containing 0.2% FBS. After 72 h in low serum, cultures were restimulated by the addition of growth medium. Cells were trypsinized 24 h after addition of serum, then washed three times with PBS and fixed in 70% ethanol overnight at 4°C. DNA was stained with PBS containing 50 µg/ml each of propidium iodide and RNase A (Boehringer Mannheim). Cell cycle profile was determined at the Core Flow Cytometry Facility of the Dana Farber Cancer Institute (Boston, MA) using a Beckton Dickinson Vantage flow cytometer and Lysis II cell cycle analysis software. All experiments were performed in triplicate.
Western blot analysis, immunoprecipitation/Western blotting, and cdk2-dependent kinase assay. Subconfluent, starvation-synchronized rat VSMCs (in 100-mm plates) were switched to growth medium with or without the addition of the indicated amounts of either control IgM or A4.1 anti-TSP1 antibodies for 16 h. Cells were washed three times with cold PBS, resuspended in 500 µl of lysis buffer (50 mM Tris · Cl pH7.4, 150 mM NaCl, 1% NP-40, 1 mM Na 3 VO 4 , 2 µg/ml aproptinin, 2 µg/ml leupeptin, 1 µM phenylmethylsulfonyl fluoride) and passed through a 26-gauge, 0.5-in. needle several times. Insoluble material was cleared by centrifugation at 13,000 rpm for 10 min at 4°C. Protein concentration of lysates was determined using the Bradford reagent (BioRad). Protein extract (50 µg) was subjected to electrophoresis on 12% SDS-PAGE and transferred to Immobilon-P (Amersham). Membranes were blocked overnight at 4°C with buffer A (0.2% Tween-20 in PBS) containing 5% nonfat milk and then were incubated at room temperature for 3 h with the indicated primary antibodies diluted in buffer A containing 2% nonfat milk. The following antibodies were used in this study: anti-p21 (sc-397, 1:200), anti-p27 (sc-528, 1:250), antip53 (sc-99, 1:250), anti-cdk2 (sc-163, 1:500), anti-cyclin A (sc-751, 1:200), and anti-cyclin E (sc-481, 1:250) (Santa Cruz Biotechnology). After several washes with buffer A, immunocomplexes were detected using an enhanced chemiluminescence (ECL) detection kit (Amersham Life Science) according to the recommendations of the manufacturer. Autoradiographs of Western blots were scanned and band intensity was determined after background subtraction using a densitometric program (Sigma Gel, Jandel Scientific).
For immunoprecipitation/Western blot-coupled assays, 200 µg of cell extract was precleared with 20 µl of Protein A/G PLUS-Agarose beads (Santa Cruz Biotechnology) for 30 min at 4°C, after which samples were incubated with 2 µg of anti-cdk2 antibodies for 3 h at 4°C. Immunocomplexes were precipitated with 20 µl of Protein A/G PLUS-Agarose beads at 4°C for 1 h. Pellets were washed three times with lysis buffer and subjected to Western blotting with anti-cdk2 antibodies as described above.
Cdk2-dependent kinase assays in cell lysates were performed using histone H1 (Boehringer Mannheim) and [␥-32 P]ATP (DuPont NEN) substrates as previously described (7) . The reaction mixtures were separated on 12% SDS-PAGE. Gels were stained with Coomassie blue (Sigma Chemical), dried, and autoradiographed.
Statistics. All results are means Ϯ SE. Statistical significance was evaluated using ANOVA followed by Scheffé's procedure for more than two means. P Ͻ 0.05 was interpreted to indicate statistical significance.
RESULTS

Neutralizing A4.1 anti-TSP1 antibody blocks seruminducible DNA synthesis in VSMCs.
We first investigated the effects of neutralizing A4.1 monoclonal anti-TSP1 antibody on [ 3 H]thymidine incorporation on serum restimulation of starvation-synchronized rat VSMCs. To this end, cells were incubated for 72 h in 0.2% FBS-DMEM and then stimulated with growth medium (10% FBS-DMEM) for 24 h, with or without the addition of A4.1 antibody. As shown in Fig. 1A We next performed flow cytometry analysis to further characterize the effect of A4.1 antibody on VSMC proliferation. In serum stimulated cultures, ϳ60 and 30% of the cells were in G 1 and S phase, respectively (Fig. 1B) . Whereas treatment of VSMCs with control IgM did not significantly affect this cell cycle profile, http://ajpheart.physiology.org/ addition of A4.1 antibody decreased the cell population in S phase to ϳ10% and augmented the population in G 1 to ϳ81%. Thus, consistent with previous studies (29) , these data demonstrate that neutralization of TSP1 function in serum-stimulated VSMCs leads to inhibition of DNA synthesis and accumulation of cells in G 1 .
Neutralizing A4.1 anti-TSP1 antibody blocks seruminducible cdk2-dependent kinase activity in VSMCs. Cdk2 function is required for progression through G 1 and S phase (15, 32, 49) . When assayed in vitro using anti-cdk2 antibodies and histone H1 as substrate, cdk2-dependent kinase activity was downregulated in both starvation-synchronized skeletal muscle cells (SKMCs) and VSMCs compared with asynchronously proliferating cells (Fig. 2A, lane Q vs. P) . Consistent with the irreversibility of cell cycle exit in striated myocytes, serum-restimulated SKMCs disclosed impaired induction of cdk2-dependent kinase activity (lane Q ϩ FBS). In marked contrast, serum-restimulated VSMCs upregulated cdk2-dependent kinase activity to a level similar to that seen in asynchronously growing cultures, demonstrating that VSMCs can reversibly regulate cdk2 function in response to mitogens. Because conditions that promote cell growth arrest were associated with inhibition of cdk2 function, we sought next to investigate the effect of A4.1 antibody on cdk2-dependent kinase activity in VSMCs. As shown in Fig. 2B , VSMCs treated with control IgM efficiently Fig. 1 . Antibody blockade of thrombospondin-1 (TSP1) inhibits seruminducible vascular smooth muscle cell (VSMC) proliferation. A: serumstarved VSMCs (solid bar) were stimulated with DMEM supplemented with 10% fetal bovine serum (FBS) and control mouse IgM (100 µg/ml, hatched bar) or with the indicated concentrations of A4.1 anti-TSP1 antibody. After 18 h, [ 3 H]thymidine was added to the medium (3 µCi/ml) and cells were incubated for an additional 6 h. [ 3 H]thymidine uptake was determined in TCA precipitates in counts/min (cpm). Each bar represents mean Ϯ SE of 3 independent experiments. * Statistically significant differences in A4.1-treated cells vs. cells treated with control mouse IgM (P Ͻ 0.01). B: A4.1 antibody blocked S-phase entry in serum-stimulated VSMCs. Starvation-synchronized VSMCs were switched to growth medium (10% FBS) supplemented with either control IgM or A4.1 antibody (100 µg/ml). After 24 h, cells were washed with PBS and harvested by trypsinization. Cells were then fixed in 70% ethanol overnight at 4°C and stained with propidium iodide. DNA content was analyzed by flow cytometry to determine cell cycle distribution. Each bar represents mean Ϯ SE of 3 independent experiments. * Statistically significant differences in A4.1-treated cells vs. cells treated with control mouse IgM (P Ͻ 0.01). http://ajpheart.physiology.org/ upregulated cdk2-dependent kinase activity on serum refeeding. In contrast, addition of A4.1 antibody to the medium blocked the normal serum-dependent induction of cdk2 activity. Thus inhibition of cdk2 activity may contribute to the cell cycle inhibitory activity of anti-TSP1 antibodies in VSMCs.
Neutralizing A4.1 anti-TSP1 antibody abrogates serum-inducible cyclin A and cyclin E expression and induces p21 Cip1/WAF1 . Having demonstrated that cell cycle arrest in A4.1-treated VSMCs is associated with impaired cdk2 function, we sought to elucidate the molecular mechanisms underlying this inhibitory effect. As shown by the Western blot analysis of Fig. 3 , addition of A4.1 antibody to serum-restimulated VSMCs had no effect on cdk2 protein levels. Because cdk2 activity during G 1 and S phase is induced in part through its association with cyclin E and cyclin A, respectively, the effect of A4.1 antibody on the expression of these regulatory subunits was also studied. Treatment of serum-restimulated VSMCs with A4.1 antibody blocked serum-inducible expression of cyclin E and cyclin A (Fig. 3) . Thus inhibition of cdk2 activity by A4.1 is associated with diminished expression of its cyclin regulatory subunits.
Because cdk2 activity can be negatively regulated through its association with the inhibitory proteins p21 and p27, we also analyzed the effect of A4.1 antibody on these growth suppressor molecules. Whereas A4.1 antibody did not affect p27 expression, its addition to serum-restimulated VSMCs markedly upregulated p21 protein levels (Fig. 3) . To test whether the induction of p21 in A4.1-treated VSMCs resulted in an increased association of p21 with cdk2-containing complexes, cell lysates were immunoprecipitated with anti-cdk2 antibodies and then the immunopellets were subjected to Western blot analysis using anti-p21 antibodies. As shown in Fig. 3 , the abundance of p21 associated with cdk2 was increased by the treatment of cells with A4.1 antibody. The lack of cdk2-bound p21 in serum restimulated cells that were not treated with A4.1 antibody (Fig. 3, lanes 2 and 3) may be caused by association of p21 with cdk4-cyclin D1 holoenzymes (23, 36) . These results suggest that upregulation of p21 and its increased association with cdk2, together with diminished cyclin A and cyclin E expression, may contribute to growth arrest in VSMCs treated with neutralizing anti-TSP1 antibody. In these studies, control mouse IgM had little or no effect on the expression of these cell cycle regulatory proteins, demonstrating the specificity of the effects elicited by the A4.1 antibody.
p21 is essential for growth suppression on antibody blockade of TSP1. The above results suggest that p21 plays an important role on cell cycle arrest in cells treated with A4.1 antibody. To further investigate the role of p21 on growth arrest induced on neutralization of TSP1 function, the effect of A4.1 antibody on [ 3 H]thymidine incorporation was tested in MEFs isolated from wild-type and p21-deficient mice. As shown in Fig. 4 , addition of A4.1 antibody inhibited in a dose-dependent manner [ 3 H]thymidine incorporation in serum-stimulated wild-type MEFs. In marked contrast, addition of A4.1 to the culture medium had little or no effect on [ 3 H]thymidine uptake in serum-stimulated p21-deficient MEFs. These findings demonstrate that p21 is essential for the cell cycle inhibitory activity of anti-TSP1 antibody.
DISCUSSION
TSP1 expression is rapidly upregulated on serum or growth factor stimulation of quiescent VSMCs (11, 28, 30) . Moreover, TSP1 protein and mRNA are detected in VSMCs within atherosclerotic lesions (26, 43, 44, 56) and during the proliferative response of VSMCs to vascular injury (42) . Consistent with the role of TSP1 as a positive regulator of VSMC proliferation, addition of neutralizing anti-TSP1 antibodies blocked seruminducible VSMC proliferation (29) . However, the mecha- Immunopellets were resuspended in sample loading buffer and separated by electrophoresis on 12% SDS-PAGE. After transfer, blot was subjected to Western blot analysis using anti-p21 antibodies. http://ajpheart.physiology.org/ nisms by which TSP1 regulates VSMC growth are not completely understood. The present study demonstrates that addition of neutralizing A4.1 antibody to cultured VSMCs blocked in a dose-dependent manner the serum-inducible activity of cdk2, a cell cycle regulator that is required for G 1 -and S-phase progression. Although cdk2 expression was not affected by the addition of A4.1 to VSMC cultures, p21 protein level was induced markedly in A4.1-treated cells. Importantly, exposure to A4.1 antibody also increased the interaction of p21 with cdk2 complexes, suggesting that upregulation of p21 contributes to the repression of cdk2 activity and cell-cycle arrest on neutralization of TSP1 function. Further evidence implicating p21 in growth arrest induced by anti-TSP1 antibody was provided using MEFs derived from either wild-type or p21-null mice. Indeed, A4.1 significantly blocked DNA synthesis in wild-type, but not in p21-null MEFs. These data together demonstrate that p21 is essential for A4.1-induced growth arrest, therefore implicating p21 as a downstream effector of TSP1.
Our results show that A4.1 antibody blocks the normal induction of cyclin A and cyclin E protein expression normally seen in serum-stimulated VSMCs. Together with the requirement of these regulatory subunits for cell cycle progression (14, 16, 17) , these data suggest that inhibition of cyclin A and cyclin E expression may contribute to growth arrest in VSMCs exposed to A4.1 antibody. It is noteworthy that serumdependent induction of cyclin A promoter activity in VSMCs and fibroblasts requires a functional E2F binding site (47, 52) . Moreover, the CKIs p16, p21, and p27 can repress transcription of E2F target genes, including cyclin A and cdc2 (7, 9, 48, 52, 59) , suggesting that blockade of cyclin A expression in VSMCs treated with A4.1 antibody may result in part from p21-dependent transcriptional repression.
The effect of CKIs, ECM components and their cellular receptors on VSMC proliferation has been the subject of recent studies. Expression of p21 and p27 in VSMCs is markedly upregulated after angioplasty at time points that coincide with the reestablishment of the quiescent phenotype (7, 53, 58) . Moreover, adenovirus-mediated overexpression of p21 (6, 55, 58) and p27 (7) attenuates VSMC hyperplasia after vascular injury in vivo. Regarding the regulation of CKI expression by specific components of the ECM, Koyama et al. (22) reported that polymerized type I collagen inhibits mitogen-inducible VSMC proliferation in vitro by upregulating p27 and p21 levels, whereas monomer collagen supported cell cycle activity (22) . Interestingly, treatment with neutralizing antibodies against ␣ 2 -integrins induced p27 and p21 expression and caused cell cycle arrest in VSMCs grown on monomer collagen (22) . These findings suggest that ␣ 2 -integrins can sense changes in collagen structure that modulate VSMC proliferation through the regulation of CKI expression. Of note, it has been shown that the TSP receptor CD47 (IAP) can associate with ␣ 2 ␤ 1 -integrin and modulate its function in VSMCs (57) . Moreover, TSP-induced VSMC proliferation in vitro is regulated by ␤ 3 -integrins, which are upregulated during injury-induced VSMC hyperplasia in vivo (51) . Thus regulation of CKI expression through specific ECM components (i.e., TSP1) appears to be an important regulator of VSMC growth.
In summary, the present study demonstrates that VSMC growth arrest on antibody blockade of TSP1 is associated with the induction of p21 and repression of cyclin A and cyclin E expression. Neutralizing A4.1 antibody failed to inhibit cell proliferation in embryonic fibroblasts derived from p21-deficient mice. These results suggest that cell cycle arrest in cells treated with neutralizing A4.1 antibody results, at least in part, from p21-dependent inhibition of cdk2 function. Taken together, these data implicate p21 in TSP1-dependent Fig. 4 . p21 is essential for A4.1-dependent cell cycle arrest in mouse embryonic fibroblasts. MEFS were isolated from wild-type (A) and p21-deficient (B) mice. Cells were serum-starved by incubation in 0.2% FBS for 72 h. Cultures were switched to growth medium (10% FBS) supplemented with either control IgM (100 µg/ml, solid bar) or with the indicated amount of A4.1 antibody. [ 3 H]thymidine was added to the culture medium 12 h postserum stimulation, cells were incubated for an additional 4 h, and incorporated label was determined by TCA precipitation. Values are means Ϯ SE of 3 experiments.
